Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 14/20 | 0.42 |
| ▸ | MMP9 | P14780 | 14/20 | 0.42 |
| ▸ | ADAM17 | P78536 | 11/20 | 0.42 |
| ▸ | MMP1 | P03956 | 13/20 | 0.41 |
| ▸ | MMP2 | P08253 | 3/20 | 0.41 |
| ▸ | MMP3 | P08254 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7324779 | 0.91 | ALDH1A1 (0.38) | MMP13MMP9ADAM17MMP1MMP2 | |
| SCHEMBL7322743 | 0.91 | ALDH1A1 (0.39) | MMP13MMP9ADAM17MMP1MMP2 | |
| SCHEMBL7322130 | 0.84 | MMP13 (0.47) | MMP13MMP9ADAM17MMP1MMP2 | |
| SCHEMBL7315991 | 0.82 | MMP13 (0.64) | MMP13MMP9ADAM17MMP1 | |
| SCHEMBL7321489 | 0.81 | MMP13 (0.47) | MMP13MMP9ADAM17MMP1MMP2 | |
| SCHEMBL7318219 | 0.80 | MMP13 (0.56) | MMP13MMP9ADAM17MMP1MMP2 | |
| SCHEMBL6815791 | 0.78 | MMP13 (0.60) | MMP13MMP9ADAM17MMP1MMP2 | |
| SCHEMBL6814832 | 0.78 | ADAM17 (0.69) | MMP13MMP9ADAM17MMP1 | |
| SCHEMBL3942775 | 0.78 | ADAM17 (0.58) | MMP13MMP9ADAM17MMP1 | |
| SCHEMBL7825679 | 0.77 | MMP13 (0.44) | MMP13MMP9ADAM17MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0938471-B1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID CO (US) | 2001-12-12 | — | — | EP | claimed |
| EP-0938471-B1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID CO (US) | 2001-12-12 | — | — | EP | disclosed |
| US-5929097-A | INHIBIT TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME | AMERICAN CYANAMID COMPANY (US) | 1999-07-27 | — | — | US | disclosed |